BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28402398)

  • 1. The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.
    LeHew CW; Weatherspoon DJ; Peterson CE; Goben A; Reitmajer K; Sroussi H; Kaste LM
    Epidemiol Rev; 2017 Jan; 39(1):132-147. PubMed ID: 28402398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010.
    Weatherspoon DJ; Chattopadhyay A; Boroumand S; Garcia I
    Cancer Epidemiol; 2015 Aug; 39(4):497-504. PubMed ID: 25976107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
    Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
    Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic differences in the incidence of oropharyngeal and oral cavity squamous cell cancers in New Zealand.
    Chelimo C; Elwood JM
    Aust N Z J Public Health; 2015 Apr; 39(2):162-7. PubMed ID: 25827186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada.
    Ghazawi FM; Lu J; Savin E; Zubarev A; Chauvin P; Sasseville D; Zeitouni A; Litvinov IV
    J Cutan Med Surg; 2020; 24(4):340-349. PubMed ID: 32238063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.
    Cleveland JL; Junger ML; Saraiya M; Markowitz LE; Dunne EF; Epstein JB
    J Am Dent Assoc; 2011 Aug; 142(8):915-24. PubMed ID: 21804058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
    Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
    Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
    D'Souza G; McNeel TS; Fakhry C
    Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers.
    Javadi P; Sharma A; Zahnd WE; Jenkins WD
    Cancer Causes Control; 2017 Jun; 28(6):635-645. PubMed ID: 28391376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and trends of HPV-related cancers other than cervix in South Africa from 1994-2013.
    Chikandiwa A; Pisa PT; Sengayi M; Singh E; Delany-Moretlwe S
    Cancer Epidemiol; 2019 Feb; 58():121-129. PubMed ID: 30557819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oropharyngeal cancer incidence trends: diminishing racial disparities.
    Brown LM; Check DP; Devesa SS
    Cancer Causes Control; 2011 May; 22(5):753-63. PubMed ID: 21380619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolving Epidemiology of Oral Cavity and Oropharyngeal Cancers.
    Chaturvedi AK; Freedman ND; Abnet CC
    Cancer Res; 2022 Aug; 82(16):2821-2823. PubMed ID: 35971675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and oropharyngeal cancer.
    Huber MA; Tantiwongkosi B
    Med Clin North Am; 2014 Nov; 98(6):1299-321. PubMed ID: 25443678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of oral-cavity and oropharyngeal carcinomas: controlling a tobacco epidemic while a human papillomavirus epidemic emerges.
    Hashibe M; Sturgis EM
    Otolaryngol Clin North Am; 2013 Aug; 46(4):507-20. PubMed ID: 23910467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States.
    Gupta S; Kong W; Peng Y; Miao Q; Mackillop WJ
    Int J Cancer; 2009 Nov; 125(9):2159-65. PubMed ID: 19569190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics.
    Mehta V; Yu GP; Schantz SP
    Laryngoscope; 2010 Nov; 120(11):2203-12. PubMed ID: 20938956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.